Aerovate Therapeutics Inc... (AVTE)
NASDAQ: AVTE
· Real-Time Price · USD
2.68
0.00 (0.00%)
At close: Apr 28, 2025, 3:59 PM
Aerovate Therapeutics Fail-to-Deliver
Total FTD Shares
43.86K
Below Average
FTD / Avg. Volume
548.76%
High Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Apr 30, 2025,
Aerovate Therapeutics Inc. has
43,862
shares failed to deliver, representing 548.76%
of the average daily volume of
7,993
shares. Over the past year, the monthly average FTD is
18,131
shares, with the current level 142% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Apr 30, 2025 | 2.68 | 43.86K | +2376.68% |
| Mar 31, 2025 | 87.85 | 1.77K | +44175.00% |
| Feb 28, 2025 | 85.05 | 4 | -99.97% |
| Jan 31, 2025 | 91.7 | 14.95K | +443.28% |
| Dec 31, 2024 | 92.75 | 2.75K | +372.85% |
| Nov 29, 2024 | 92.05 | 582 | +903.45% |
| Oct 31, 2024 | 85.75 | 58 | -98.04% |
| Sep 30, 2024 | 73.15 | 2.96K | +2215.63% |
| Aug 28, 2024 | 65.1 | 128 | +113.33% |
| Jul 30, 2024 | 63.7 | 60 | -99.66% |
| Jun 27, 2024 | 58.45 | 17.59K | +35806.12% |
| May 31, 2024 | 610.75 | 49 | -92.34% |
| Apr 29, 2024 | 719.25 | 640 | -85.31% |
| Mar 28, 2024 | 1034.95 | 4.36K | +57.35% |
| Feb 29, 2024 | 807.8 | 2.77K | +1093.53% |
| Jan 23, 2024 | 709.1 | 232 | -78.58% |
| Dec 26, 2023 | 812 | 1.08K | +20.07% |
| Nov 24, 2023 | 556.15 | 902 | +1188.57% |
| Oct 30, 2023 | 349.3 | 70 | -78.59% |
| Sep 28, 2023 | 479.85 | 327 | -0.91% |
| Aug 14, 2023 | 523.25 | 330 | -69.04% |
| Jul 31, 2023 | 610.75 | 1.07K | -9.66% |
| Jun 30, 2023 | 600.25 | 1.18K | +98.65% |
| May 31, 2023 | 568.75 | 594 | -69.91% |
| Apr 28, 2023 | 733.95 | 1.97K | +385.01% |
| Mar 31, 2023 | 705.95 | 407 | -88.59% |
| Feb 28, 2023 | 859.95 | 3.57K | -34.76% |
| Jan 31, 2023 | 799.75 | 5.47K | n/a |